List of Methylin drug patents

Methylin is owned by Specgx Llc.

Methylin contains Methylphenidate Hydrochloride.

Methylin has a total of 1 drug patent out of which 0 drug patents have expired.

Methylin was authorised for market use on 19 December, 2002.

Methylin is available in solution;oral dosage forms.

The generics of Methylin are possible to be released after 07 October, 2024.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7691880 SPECGX LLC Methylphenidate solution and associated methods of administration and production
Oct, 2024

(1 year, 7 months from now)

Drugs and Companies using METHYLPHENIDATE HYDROCHLORIDE ingredient

Market Authorisation Date: 19 December, 2002

Treatment: NA

Dosage: SOLUTION;ORAL

How can I launch a generic of METHYLIN before it's patent expiration?
More Information on Dosage

METHYLIN family patents

3

United States

1

China

1

Austria

1

Australia

1

Spain

1

Canada

1

Mexico

1

Japan

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in